Community acute care models, risk stratification gaps, and prescribing safety: week ending 27 June 2026

The evidence base for community-based acute care crossed a significant threshold this week. Hospital-at-Home now has strong randomised evidence for preserving physical function, but the risk stratification tools needed to deliver it safely in community settings are demonstrably inadequate. Separately, a meta-analysis revealed an urgent prescribing safety signal for ceftriaxone — the most widely used antibiotic for outpatient intravenous therapy.

Two national policy developments frame the clinical evidence. The government’s response to Baroness Casey (22 June) confirmed the first concrete timeline for a Frailty and Dementia Modern Service Framework — an interim in September, full framework by year-end 2026 — alongside a Dementia Tsar and a National Safeguarding Board. A House of Lords debate (25 June) produced the government’s confirmation of an 80% within 18 weeks community health services waiting time target by 2028–29, the first formal community services metric of its kind. Between them, the resident doctors referendum closed on Friday with the result still pending; the outcome will determine whether 4,000–4,500 specialty training posts enter the allocation pipeline or the system returns to industrial action contingency. The clinical evidence arriving this week — demonstrating both the effectiveness and the safety infrastructure gaps of community acute care — lands at precisely the moment these national frameworks are being written.

Acute Frailty

The evidence base for Hospital-at-Home crossed a threshold this week. Larsen et al. (JAMA Network Open 9(6):e2618812; PMID 42329654) conducted a hybrid randomised clinical trial at a regional public hospital in Denmark, randomising 111 patients to Hospital-at-Home or standard inpatient care. HaH participants gained 1,763 more steps in the first 24 hours (95% CI 153–3,373; p=0.03) — the strongest functional preservation evidence to date — with higher patient satisfaction (mean 4.41 versus 4.10; p=0.04) and no safety signal across 7-, 30-, and 90-day mortality and readmissions. Fernández Bermejo et al. (Revista Española de Geriatría y Gerontología 61(4):101811; PMID 42302417) demonstrated the feasibility of HaH for acute decompensated heart failure in the very old (n=41, median age 91.5 years) in a prospective observational study, with zero deaths during the HaH episode and a 9.8% transfer rate to conventional hospitalisation.

But the safety infrastructure has not kept pace. Scott et al. (PLoS One 21(4):e0347678; PMID 42048369) analysed 2,533 virtual ward admissions across five care pathways and found NEWS2 — the standard acuity monitoring tool — has an AUC of just 0.55 for predicting hospital readmission, barely above chance. Ten per cent of patients had high clinical acuity (NEWS2 ≥5) on admission, and 9% reached NEWS2 ≥7 during their stay, yet the score did not distinguish those who would require escalation from those who would not. The authors noted that the NEWS2 distribution on virtual ward admission was similar to that observed in the 2022 Society for Acute Medicine Benchmarking Audit — the same score distribution as acute hospitals, but without the predictive discrimination that makes it clinically useful in that setting. This creates a specific governance gap: the models for community acute care are evidentially sound, but the risk tools underpinning clinical safety were designed for acute hospital populations and do not discriminate effectively in community settings.

Suraarunsumrit et al. (BMC Geriatrics; PMID 42237253) provided cost-utility evidence for comprehensive geriatric assessment in a three-arm study (n=226) at a tertiary hospital in Thailand. CGA-ward care produced a utility score improvement of 0.259 (EQ-5D-5L) and a Barthel Index improvement of 37.94 points, with a QALY gain of 0.130 and a cost saving of US$937 per patient compared with usual care. CGA-consult was also cost-effective, with a QALY gain of 0.047 and a saving of US$552 per patient. While from a different health system, the economic case for dedicated CGA wards versus consultation-only models adds to the evidence base on optimal frailty service configuration.

Clinical Psychology

Stratmann et al. (Archives of Gerontology and Geriatrics 149:106310; PMID 42208196; n=3,972) demonstrated that persistent — not transient — depressive symptoms in older adults are associated with significantly higher morbidity burden, poorer physical functioning, and elevated specialist healthcare use. Using longitudinal data from the German Ageing Survey, the study defined four depressive symptom trajectories: no symptoms (68.5%), incident (11.7%), remitted (8.8%), and persistent (10.9%). The persistent group showed the strongest associations with adverse outcomes. Specialist healthcare use remained elevated for the persistent group even after adjusting for physical health status, suggesting a direct effect beyond the mediation of physical functioning. This positions psychological status as a determinant of functional capacity rather than a parallel clinical concern, and reinforces the case for integrated psychological assessment within frailty and community services. Areas of high socioeconomic deprivation predict higher prevalence of persistent depression in older adults; the finding that persistent rather than transient symptoms drive healthcare use supports targeted, sustained psychological intervention rather than single-episode screening.

Palliative Care

Two studies converge on advance care planning and hospice access. Wang et al. (Annals of Medicine 58(1):2670058; PMID 42143211) analysed 5,127 non-cancer decedents over a ten-year period at a tertiary hospital in Taiwan and found only 7% received hospice care, with 60.2% of those enrolling within 7 days of death. Advanced heart disease (aOR 1.95) and end-stage renal disease (aOR 1.96) were associated with high aggressive end-of-life care scores, while hospice enrolment was associated with lower odds of aggressive care (aOR 0.46). Klunder et al. (European Journal of General Practice 32(1):2650928; PMID 42095496) explored Dutch primary care professionals’ perspectives and identified advance care planning and continuity of care as the two most important factors mitigating unplanned hospital admissions in older adults, with out-of-hours vulnerability and fragmented community services as key drivers of avoidable admission.

These findings, while from non-UK settings, address a pattern that is consistent across health systems: non-cancer diagnoses receive substantially less hospice and palliative care input than cancer diagnoses, and the structural conditions that prevent avoidable admissions — continuity, advance planning, carer support — are relational and organisational rather than documentary. National ACP Day (1 July) arrives with this evidence base strengthened: the case for earlier advance care planning is now supported across multiple study designs and populations, and the enabling conditions are increasingly well characterised.

Therapies and AHPs

Hicks et al. (Ageing Research Reviews 120:103207; PMID 42320833) produced an individual participant data meta-analysis of 28 studies (n=7,608) challenging the standard gait speed threshold for fall risk screening. The World Falls Guidelines’ <0.8 m/s cut-point has a sensitivity of only 35% and a specificity of 77%. Walking at <0.8 m/s was associated with increased risk of falling (RR 1.27, 95% CI 1.17–1.38) and an elevated fall rate (IRR 1.54, 95% CI 1.34–1.77), but discriminative accuracy was modest. A <1.0 m/s threshold produced similar effect sizes and accuracy metrics but identified substantially more at-risk fallers in both community-dwelling populations (30.1% versus 8.7%) and clinical populations (66.9% versus 46.0%). Community physiotherapy teams using gait speed for fall risk screening should review current thresholds in light of this evidence.

OPAT

Maraolo et al. (Annals of Medicine 58(1):2667672; PMID 42112603) conducted a meta-analysis of 11 studies totalling 2,568 patients and found ceftriaxone carries a threefold mortality increase (OR 3.33, 95% CI 2.17–5.10) compared with antistaphylococcal penicillins or cefazolin for MSSA bloodstream infections. The difference at 90 days was not statistically significant (OR 1.71; 95% CI 0.75–3.90). This is the week’s most urgent clinical signal. Ceftriaxone is the default OPAT antibiotic due to once-daily dosing convenience; this evidence demands review of ceftriaxone use for confirmed MSSA bacteraemia across services that currently treat this indication with ceftriaxone.

Helleren et al. (JAC-Antimicrobial Resistance 8(3):dlag052; PMID 42100600) showed OPAT via CADD pump delivers 88% cost savings versus inpatient care (€1,603 versus €12,982 per episode, 51 bed-days saved per month) in a Norwegian publicly funded health system. Critically, CADD pumps enable continuous beta-lactam infusion at home, providing the delivery mechanism for safer alternatives to ceftriaxone. These two findings together present a case for OPAT service model evolution: investing in pump infrastructure to deliver safer antibiotics without losing the benefits of community-based treatment, while simultaneously supporting antimicrobial stewardship through narrower-spectrum prescribing.

Synthesising observation

The convergence this week is between strategic direction and operational readiness. Community-based acute care, integrated frailty pathways, earlier palliative conversations, and OPAT expansion are all now evidentially supported and politically endorsed. The Lords debate, the Casey MSF timeline, and the HaH trial evidence point in the same direction. But the operational infrastructure is not ready for what the strategy demands. NEWS2 does not work on virtual wards. Standard gait speed thresholds miss at-risk fallers. Ceftriaxone — the convenience antibiotic that makes OPAT logistically simple — carries a threefold mortality risk for a common indication. The national direction of travel is aligned with where care should be delivered; it has not yet reckoned with the maturity of the tools, processes, and workforce needed to deliver it safely. The Modern Service Framework interim, due in September, will be written into this gap — whether it acknowledges it or not will determine its usefulness.

The resident doctors referendum result, expected imminently, will determine whether 4,000–4,500 specialty training posts enter the allocation pipeline — and with them, the opportunity to build training capacity in geriatric medicine, palliative medicine, and acute medicine. The Public Accounts Committee response to the frailty inquiry, due 22 June, has not yet been published.